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Abstract  37 
Background 38 
Chronic obstructive pulmonary disease (COPD) results in exercise intolerance. Dietary 39 
nitrate supplementation has been shown to lower blood pressure (BP), reduce the oxygen cost 40 
of exercise, and enhance exercise tolerance in healthy volunteers. This study assessed the 41 
effects of dietary nitrate on the oxygen cost of cycling, walking performance and BP in 42 
individuals with mild-moderate COPD.  43 
Methods 44 
Thirteen patients with mild-moderate COPD were recruited. Participants consumed 70 ml of 45 
either nitrate-rich (6.77 mmol nitrate; beetroot juice) or nitrate-depleted beetroot juice (0.002 46 
mmol nitrate; placebo) twice a day for 2.5 days, with the final supplement ~3 hours before 47 
testing. BP was measured before completing two bouts of moderate-intensity cycling, where 48 
pulmonary gas exchange was measured throughout. The six-minute walk test (6MWT) was 49 
completed 30 minutes subsequent to the second cycling bout.  50 
Results 51 
Plasma nitrate concentration was significantly elevated following beetroot juice vs. placebo 52 
(placebo; 48 ± 86 vs. beetroot juice; 215 ± 84 µM, P=0.002). No significant differences were 53 
observed between placebo vs. beetroot juice for oxygen cost of exercise (933 ± 323 vs. 939 ± 54 
302 ml: min-1; P=0.88), distance covered in the 6MWT (456 ± 86 vs.  449 ± 79 m; P=0.37), 55 
systolic BP (123 ± 14 vs.  123 ± 14 mmHg; P=0.91), or diastolic BP (77 ± 9 vs. 79 ± 9 56 
mmHg; P=0.27).  57 
Conclusion 58 
Despite a large rise in plasma nitrate concentration, two days of nitrate supplementation did 59 
not reduce the oxygen cost of moderate intensity cycling, increase distance covered in the 60 
6MWT, or lower BP. 61 
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INTRODUCTION 62 
Exercise in individuals with COPD is limited by multiple factors which can result in 63 
hypoxemia. These include loss of normal lung architecture, impaired cardiac function [1], 64 
abnormal pulmonary blood flow distribution [2] and peripheral muscle de-conditioning [3]. 65 
Oxygen uptake in the lungs and delivery of oxygen to working muscle is impaired by 66 
increases in pulmonary blood flow which increase shunting through blood vessels resulting in 67 
incomplete gas exchange [4] and cor pulmonale later in the disease course. These 68 
abnormalities result in feelings of breathlessness and fatigue [5], with individuals often 69 
finding that activities of daily living are physically challenging.  70 
The beneficial effects of a diet rich in vegetables upon cardiovascular health [6],  risk 71 
of morbidity and mortality [7], and COPD development [8; 9] have been well described. 72 
These positive effects have, in part, been attributed to inorganic nitrate which is found in 73 
particularly high quantities in leafy green vegetables and some root vegetables such as 74 
beetroot [10]. Nitrate supplementation in the form of sodium nitrate or nitrate-rich beetroot 75 
juice has been shown to have remarkable effects in healthy young individuals and athletes, 76 
including reductions in the oxygen cost of exercise [11], enhanced exercise 77 
tolerance/performance and reduced blood pressure (BP) [11; 12]. Some of these effects have 78 
subsequently been observed in individuals with peripheral artery disease following dietary 79 
nitrate supplementation [13]. These findings have been attributed to an increase in the 80 
bioavailability of nitric oxide (NO). 81 
NO is a signalling molecule with multiple functions including regulation of vascular 82 
tone, mitochondrial respiration and skeletal muscle function [14; 15; 16]. These factors are 83 
important in the physiological response to exercise. NO is produced in two distinct ways in 84 
man. The best known is the classical L-arginine nitric oxide synthase (NOS) pathway which 85 
is oxygen dependent [17]. The second is the entero-salivary pathway and is oxygen 86 
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independent. Briefly, nitrate from the diet is rapidly and extensively absorbed in the stomach 87 
and proximal small intestine with bioavailability approaching 100% [18]. Nitrate is then 88 
concentrated in the salivary glands, with concentrations 10 fold greater in saliva than in 89 
plasma. Nitrate secreted in saliva is reduced to nitrite by facultative anaerobic bacteria on the 90 
dorsum of the tongue [19]. On swallowing, the acidic environment of the stomach results in 91 
NO formation with important local effects on gastric function and host defence [6; 20]. Some 92 
nitrite is absorbed into the circulation where it acts as a storage pool for subsequent NO 93 
production [14]. The conversion of nitrite to NO is expedited in conditions of acidosis [21] or 94 
hypoxemia [14] which often occur in the exercising muscle of individuals with COPD [22].  95 
In many individuals with COPD, functional capacity is reduced to a level where 96 
activities of daily living may impose a challenge due to an energy requirement representing a 97 
high fraction of their maximal oxygen uptake. While a number of cardiovascular and 98 
physiological benefits have been shown as a result of dietary nitrate supplementation in 99 
healthy populations, little is known about possible effects in clinical populations. We aimed 100 
to determine whether dietary nitrate supplementation has a beneficial impact upon the oxygen 101 
cost of sub-maximal cycling exercise, walking performance and BP in individuals with 102 
COPD.  103 
Purpose 104 
 The aim of this study was to assess the effects of 2.5 days of dietary nitrate 105 
supplementation on the oxygen cost of sub-maximal cycling, walking performance, and 106 
resting BP in individuals with mild-moderate COPD.  107 
METHODS 108 
Patients 109 
Fourteen individuals with mild-moderate COPD (see Table 1 for patient 110 
characteristics) gave written informed consent to participate in this double-blind, placebo-111 
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controlled, cross-over design study between April 2013 and January 2014.  The study was 112 
registered as a clinical trial at ClinicalTrials.gov (NCT01712386). The Exeter NRES 113 
Committee gave ethical approval (12//SW//0327). Patients were recruited if lung function 114 
was between 30-80% of predicted FEV1 values, aged 40-75 years old and able to give 115 
informed consent. Participants were excluded if they had chronic kidney disease (estimated 116 
glomerular filtration rate <30 ml/min/1.73 m2), uncontrolled hypertension (systolic BP> 160 117 
mmHg or diastolic >100 mmHg), were smokers (smoked within past 3 months), consumed 118 
regular organic nitrate or nicorandil. Patients taking phosphodiesterase inhibitors were asked 119 
to refrain from doing so for the duration of the study.  120 
Pre-experimental tests 121 
Participants arrived at the Heart and Lung unit at Torbay hospital where informed 122 
consent, medical history, anthropometric measures, BP, lung function and an ECG were 123 
performed. Participants completed a ramp incremental cycle ergometer test (10 W∙min-1) to 124 
determine their gas exchange threshold (GET). Breath-by-breath pulmonary gas exchange 125 
was measured throughout and the GET was determined using the V-slope method as 126 
described previously [23].  127 
Experimental Overview 128 
Participants consumed 70 ml of nitrate-rich beetroot juice (beetroot juice; 6.77 mmol 129 
nitrate; Beet it, James White Drinks Ltd., Ashbocking, UK) or nitrate- depleted beetroot juice 130 
as a placebo (placebo; 0.002 mmol nitrate; Beet it, James White Drinks Ltd., Ashbocking, 131 
UK), with one beverage in the morning and one in the evening for two days preceding 132 
testing. On study days, participants consumed a final 70 ml beetroot juice drink ~3 hours 133 
prior to exercising. Participants self-reported concordance with the supplementation regime 134 
which was confirmed by measurement of plasma nitrate concentration. After exercise testing 135 
the participants began a washout period (7 days) before entering the opposing arm of the 136 
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study. The placebo was indistinguishable from the nitrate-rich juice in taste, colour, texture, 137 
appearance and odour as described previously [24].  138 
Participants arrived at the laboratory in a fully hydrated state, having avoided 139 
consumption of caffeine, alcohol, cruciferous vegetables, leafy greens, beetroot, and 140 
completion of strenuous exercise 24 hours prior to testing. Participants were asked to record 141 
their food intake for 24 hours prior to testing and to replicate this after the crossover and this 142 
was verbally confirmed on the second exercise visit. Participants avoided antibacterial 143 
mouthwash for 7 days prior to testing. Participants arrived 45 minutes before the initiation of 144 
exercise following ingestion of the randomised juice with their morning meal. Brachial artery 145 
BP was taken, after a 10 minute resting period whilst supine, with an automated 146 
sphygmomanometer (Omron M6, Kyoto, Japan). Five measurements were performed and the 147 
mean of the last three was recorded. Venous blood was drawn and processed for plasma 148 
nitrate concentration as per our previously described chemiluminescence technique [25]. 149 
Participants completed two bouts of cycling at 80% of their GET on a cycle ergometer 150 
(Ergoselect 100, Bitz, Germany) with 30 minutes recovery between bouts. Following 30 151 
minutes rest, participants performed a six-minute walk test to assess functional capacity. 152 
Participants walked around a clear rectangular corridor (14 x 12m) for a total of 52m per lap, 153 
covering as much distance as possible. Standardised verbal encouragement was given 154 
throughout.  155 
Measurements  156 
Pulmonary gas exchange and ventilation were measured during the cycling exercise 157 
(VmaxTM Encore, Yorba, Linda, CA). Before each session the analysers were calibrated using 158 
gases of known concentration.  The volume transducer was calibrated using a 3-litre syringe 159 
(Hans Rudolph, Kansas City, MO, USA).  160 
Outcome measures 161 
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Primary outcome measure: does 2.5 days of nitrate supplementation reduce the 162 
oxygen cost of moderate intensity cycling? Secondary outcome measure (i): does 2.5 days of 163 
nitrate supplementation improve functional capacity as measured via the six-minute walk 164 
test?  Secondary outcome measure (ii): does 2.5 days of nitrate supplementation reduce 165 
resting BP?  166 
Sample size and randomisation 167 
An a priori sample size calculation was performed. Previous literature in healthy 168 
young volunteers has shown a mean change between beetroot juice and control of 69 ml for 169 
end exercise pulmonary oxygen uptake (V̇O2) (1SD) and 121 ml for V̇O2 amplitude (2SD) 170 
[11]. For 90% power and an α-level set at P=0.05 (two tailed), to detect a 1 SD difference 13 171 
patients were required. The reproducibility of these measures in patients with COPD are 172 
similar to healthy controls [26]. An unrestricted computer generated sequence was used by a 173 
research nurse to assign each participant a randomisation number and supply them with the 174 
requisite juice.  175 
Data and statistical analysis 176 
Participant’s breath by breath V̇O2 data were initially checked for erroneous breaths 177 
(caused by coughing and swallowing). Breaths > 4 SDs away from the local mean were 178 
removed prior to interpolation. Breath by breath data for each cycling bout were time aligned 179 
and interpolated to provide second by second values. A nonlinear least squares algorithm was 180 
then used to fit the ensemble-averaged data.  The overall V̇O2 kinetics were described using 181 
the mean response time (MRT), which was calculated by fitting a single exponential curve to 182 
the data with no time delay from the onset to the end of exercise. The oxygen deficit was 183 
calculated as the product of the V̇O2 response amplitude (i.e. the baseline to the point that a 184 
steady state was attained) and the MRT.  For a schematic representation of the kinetics 185 
parameters, please see figure 1.  186 
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All data were tested for normality. Statistical differences were assessed using paired t-187 
tests for normally distributed data and Wilcoxon rank-sum test for non-normally distributed 188 
data. All data are presented as means ± standard deviation (SD). Statistical analysis was 189 
performed on SPSS software version 21.0 (Chicago, IL, USA). Statistical difference was 190 
accepted when P < 0.05.  191 
Results  192 
 14 individuals with COPD provided written informed consent. Following screening, 193 
one individual was withdrawn due to FEV1 < 30%. 13 participants were randomised to start 194 
in either the beetroot juice or placebo condition of the study. All participants reported 100% 195 
adherence to the supplementation regime. Participants reported similar dietary patterns and 196 
physical activity during both study arms. Dietary nitrate supplementation was well tolerated 197 
with no adverse events apart from red stools and beeturia, as in previous studies [11].  198 
Plasma nitrate concentration: Relative to placebo, beetroot juice significantly 199 
increased plasma nitrate concentration (48 ± 85 vs. 215 ± 84µM, P = 0.002, 95% CI 75, 260; 200 
Figure 2).  201 
Effects on the oxygen cost of cycling exercise: The group mean pulmonary V̇O2 202 
response to exercise for both placebo and beetroot juice conditions can be seen in figure 3, 203 
with the V̇O2 kinetics resulting from the model fits displayed in Table 2. Relative to placebo, 204 
beetroot juice supplementation had no effect on baseline V̇O2 (634 ± 233 vs. 622 ± 253 205 
ml∙min-1, P = 0.56, 95% CI     -57, 32) or end exercise V̇O2 (933 ± 323 vs. 939 ± 302 ml∙min-206 
1, P = 0.88, 95% CI -68, 78). There were no differences between conditions for the MRT (P = 207 
0.90, CI -25, 28) or the oxygen deficit (P = 0.71, CI -.2, .3) (Table 2).  208 
Effects on functional capacity: There was no difference between conditions for 209 
distance covered during the six-minute walk test (456 ± 86 vs.  449 ± 79 m, P = 0.17, 95% CI 210 
-22, 9). 211 
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Effects on resting blood pressure: Compared to the placebo juice, beetroot juice did 212 
not significantly reduce systolic BP (123 ± 14 vs. 123 ± 14 mmHg, P = 0.91, 95% CI -5, 4) or 213 
diastolic BP (78 ± 9 vs. 79 ± 9 mmHg, P = 0.25, 95% CI -2, 5; Figure 4).  214 
Discussion  215 
 Beetroot juice supplementation, (nitrate; 6.77 mmol) twice daily, for 2.5 days did not 216 
reduce the oxygen cost of cycle ergometer exercise, improve functional capacity or reduce 217 
resting BP in individuals with COPD. There was no difference between conditions for these 218 
variables despite a statistically significant and physiologically meaningful rise in plasma 219 
nitrate concentration following nitrate supplementation. Possible explanations for the lack of 220 
effect in this study include nitrate dosage, efficacy of nitrate reduction to nitrite, oxidative 221 
stress, and the age of the participants.  222 
Nitrate supplementation and effects on plasma nitrate concentration. 223 
 Plasma nitrate concentration was 48µM post placebo and 215µM following nitrate-224 
rich beetroot juice, which is consistent with much of the literature in healthy young 225 
individuals [27; 28] and individuals with type 2 diabetes [24]. Similar changes in plasma 226 
nitrate concentrations have been shown to elicit reductions in the oxygen cost of exercise, 227 
improved exercise tolerance/performance and reductions in BP [29; 30; 31]. Due to logistical 228 
constraints, plasma nitrite concentration was not assessed in this study. In all previous studies 229 
involving dietary nitrate supplementation where plasma nitrite concentration has been 230 
determined, a rise in plasma nitrate concentration similar to the magnitude observed in the 231 
present study has been accompanied by a physiologically meaningful and statistically 232 
significant rise in plasma nitrite concentration [16; 29; 30]. However, we cannot exclude the 233 
possibility that there is an impaired capacity for reduction of nitrate to nitrite in individuals 234 
with COPD. Such an impairment could potentially be related to differences between 235 
A 
B 
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individuals with COPD and healthy individuals in oral microflora due to oral steroids and 236 
repeated exposure to courses of antibiotics [32]. 237 
Nitrate supplementation and effects on the oxygen cost of cycling exercise. 238 
 We found no reduction in the oxygen cost of cycling exercise at baseline or end-239 
exercise in individuals with COPD following nitrate-rich beetroot juice supplementation 240 
compared to placebo. Nitrate supplementation in healthy young individuals has previously 241 
resulted in reductions in the oxygen cost of exercise [11]. However, we recently reported that 242 
the oxygen cost of exercise was not altered by dietary nitrate supplementation in a group of 243 
healthy older adults [33]. The current study is the first to examine the effects of nitrate 244 
supplementation on the oxygen cost of exercise in any clinical population. The 245 
supplementation regime used in this study, consisting of 6.77 mmol  twice a day for 2.5 days,  246 
has previously been shown to increase plasma nitrite concentrations [11; 34; 35] and elicit 247 
reductions in the oxygen cost of exercise [30]. It is therefore unlikely that the dosage and the 248 
timing of nitrate supplementation explain why no effect on the oxygen cost of exercise was 249 
observed.  250 
 One possible explanation for the reduction in oxygen cost following dietary nitrate 251 
supplementation in other populations is an increase in the P/O ratio (i.e. less oxygen being 252 
consumed to produce a given amount of ATP). Larsen et al [16] reported an increase in the 253 
P/O ratio of harvested mitochondria following three days nitrate supplementation. However, 254 
we did not observe a reduction in the oxygen cost of exercise, which may be related to the 255 
impact of oxidative stress, which is reported to damage mitochondrial membranes [36], 256 
potentially resulting in a reduction in the P/O ratio. COPD is associated with increased 257 
oxidative stress, with reactive oxygen species (ROS) being produced within the inflammatory 258 
cells and epithelial cells of the airways in conjunction with increased systemic generation of 259 
ROS [37]. Oxidative stress leads to uncoupling of the NO synthase enzymes [38], thus 260 
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reducing NO bioavailability and creating a negative feedback loop of diminishing NO 261 
production and elevated NO scavenging. This may be a substantial barrier to NO based 262 
therapeutics in COPD.   263 
Nitrate supplementation and effects on functional capacity. 264 
 No statistical difference in distance covered for the six-minute walk test was 265 
observed between conditions. Considering that the oxygen cost of exercise and rate of 266 
adaptation of V̇O2 were not altered following nitrate supplementation, it is perhaps not 267 
surprising that functional capacity was also not different between conditions.  It is likely that 268 
these lack of effects share a common explanation, which may be related to the impact of 269 
oxidative stress on the bioavailability of NO [38] (see previous section).  270 
The only other studies that have examined the impact of dietary nitrate 271 
supplementation on walking performance have reported both positive and neutral effects.  272 
Kenjale et al [13] reported an increased walking time to exhaustion (17%) in a cohort of 273 
peripheral artery disease patients. However, dietary nitrate supplementation had no effect on 274 
the distance covered in a six-minute walk test in healthy older individuals[33]. Since plasma 275 
nitrate (and nitrite in [11 33]) concentrations were similar for the present study and two 276 
previous studies, the differences in walking performance post-nitrate supplementation are 277 
likely related to methodological differences. Kenjale et al [13] assessed walking performance 278 
via an incremental test to exhaustion on a treadmill, whereas in the present study and that of 279 
Kelly at al [33] walking performance was assessed via completion of a (submaximal) six-280 
minute walk test. It is likely that the higher exercise intensity encountered by the participants 281 
in Kenjale et al [13] resulted in the development of a hypoxic and acidic cellular environment 282 
that is known to be conducive for the reduction of nitrate to nitrite [21]. Such an environment 283 
would have been less likely to occur during the lower exercise intensity in the present and 284 
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Kelly et al’s study [33].  Finally, Kenjale et al, [13] did not use a placebo that was 285 
indistinguishable from their active juice, thus a ‘placebo effect’ cannot be ruled out.  286 
Nitrate supplementation and effect on resting BP. 287 
 There was no difference in systolic or diastolic resting BP following nitrate-rich 288 
beetroot juice compared to placebo. This may be related to a factor specific to COPD such as 289 
the elevated oxidative stress [37] in this population would be expected to increase the 290 
scavenging of NO, thus reducing its effectiveness. Alternatively there are multiple other 291 
factors which may modify the BP effect. Studies investigating the effects of dietary nitrate 292 
supplementation in older subjects with and without pathology have reported inconsistent BP 293 
effects. Gilchrist et al [25] examined the impact of dietary nitrate supplementation in 294 
individuals with type 2 diabetes, and found no statistical difference in mean 24h ambulatory 295 
BP. In subjects with peripheral artery disease Kenjale et al [13] reported a statistically 296 
significant reduction in diastolic BP (7 mmHg) but no change in systolic BP. It is possible 297 
that ageing per se may attenuate NO mediated BP reduction, however in Kelly et al’s [33] 298 
study of healthy older adults dietary nitrate supplementation resulted in reductions in systolic 299 
and diastolic BP of 5 and 3 mmHg, respectively. In contrast, more recently, a larger study by 300 
Bondonno et al [39] used a vegetable based, nitrate rich diet for 7 days. Ten hour ambulatory 301 
BP along with home and office based measurements were used to assess BP. They found no 302 
reductions in BP or arterial stiffness. There are key differences around the supplementation 303 
protocol and timing and method of blood pressure measurement. In Kelly et al’s study the 304 
office based blood pressure measurement was timed to coincide with the plasma nitrite peak 305 
post nitrate ingestion. In the Bondonno et al study measurements took place outside this 306 
window.  307 
It is also worth noting the differing BMI’s in these studies and our present manuscript. 308 
Kelly et al’s cohort of older adults are the only group in the normal range (24±3 kg/m2). Our 309 
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present cohort had a mean BMI of 29 ± 8kg/m2, Bondonno et al’s cohort were overweight 310 
27±4 kg/m2, and  in our previous study of subjects with type 2 diabetes the group mean BMI 311 
was 30.8±3.2 kg/m2. This raises the possibility that adiposity may attenuate the response to 312 
inorganic nitrate by an as yet unknown mechanism.    313 
One factor which may have had an impact is that subjects in the present study were 314 
taking multiple classes of drugs including antihypertensives. It is possible that the scope for 315 
reductions in BP subsequent to nitrate supplementation is significantly reduced when 316 
individuals are already taking antihypertensive medication. It is noteworthy that in studies 317 
where subjects were taking antihypertensives (current study - 38% prescribed 318 
antihypertensives; Gilchrist et al [25] - 98% prescribed antihypertensives), no reductions in 319 
BP have been reported (see table 1 for drug classifications). Alternatively, the  healthy older 320 
adults, on no medications, studied by Kelly et al [33] showed a significant reduction in BP 321 
following nitrate supplementation.  It is possible that antihypertensive agents mitigate the NO 322 
mediated reduction in BP.   323 
There is conflicting evidence to suggest that ACEi/ARBs can alter the bioavailability 324 
of NOx with some studies showing reduction [10] and others proposing increases [8; 9]. 325 
Therefore the direction in which ACEi/ARBs may alter the bioavailability of NO remains 326 
unclear. ß2-adrenergic receptor agonists are known to increase endothelial NO production 327 
and are at least, in part, responsible for their vasodilatory effects [11]. ß2-agonists are the 328 
most common treatment for individuals with COPD and thus we could not reasonably 329 
exclude individuals who were prescribed this medication. We cannot exclude the possibility 330 
that prescribed medications which modulate NO bioavailability may attenuate a beneficial 331 
effect from dietary nitrate supplementation. This study is a crossover design and therefore 332 
both treatment arms will be equally affected. Further study is required to better understand 333 
the possible interaction of different medications and inorganic nitrate and nitrite. 334 
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Berry et al. [6] recently examined the effect of nitrate rich beetroot juice vs. prune 335 
juice (as a placebo) in individuals with COPD. Plasma nitrite concentration was significantly 336 
higher post beetroot juice compared to post prune juice, which indicates that the entero-337 
salivary pathway is operational in people with COPD. The authors reported reductions in 338 
resting systolic BP, iso-time (defined as: last 60s of the shortest exercise time during either 339 
active or placebo visits compared with the same time point from the longer exercise time) BP, 340 
end exercise diastolic BP and an improvement in exercise tolerance (i.e. lengthened time to 341 
exhaustion during submaximal constant rate). Whilst the increase in exercise time is of 342 
interest, there are significant limitations in this study. Firstly, the design utilises prune juice 343 
as the placebo, which is likely to  have a substantially different antioxidant content which 344 
could alter NO bioavailability [7]. Secondly, and related to the lack of a ‘true’ placebo where 345 
the participant did not know whether active or placebo juice was being taken (as used in the 346 
present study), the widely reported (in the national press as well as in scientific literature) 347 
beneficial effects of beetroot juice on exercise performance/tolerance may have given rise to 348 
a placebo effect in informed volunteers. The authors do not show a reduction in the oxygen 349 
cost of exercise which is consistent with the present study. However, with no reduction in the 350 
oxygen cost of exercise, it is not immediately clear what mechanism  underpins the improved 351 
time to exhaustion reported by Berry et al. [6].  352 
This is the first double blind,  randomised, placebo, controlled, crossover design  353 
study to examine the effects of nitrate supplementation on the oxygen cost of exercise, 354 
walking performance and BP in individuals with COPD.  The study had a robust 355 
experimental design (double-blind, placebo-controlled, randomised, cross-over study). A 356 
limitation is that we were not able to ascertain whether or not the increase in plasma nitrate 357 
concentration lead to an increase in plasma nitrite concentration, as we were not able to 358 
measure the latter due to logistical constraints. However, a recent study examining nitrite 359 
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levels in individuals with COPD did show elevated plasma nitrite concentrations [44] which 360 
suggests the entero-salivary pathway is operational.    361 
Conclusion        362 
  In contrast to findings in healthy young individuals, and despite a statistically 363 
significant and physiologically meaningful rise in plasma nitrate concentration, 2.5 days of 364 
beetroot supplementation with 6.77 mmol of nitrate twice daily did not reduce the oxygen 365 
cost of cycling exercise, improve functional capacity or reduce resting blood pressure. 366 
Potential explanations for the lack of effect include a reduced P/O ratio due to systemic ROS 367 
generation associated with oxidative stress, or a reduced conversion of nitrate to nitrite in this 368 
population.  369 
Acknowledgments  370 
This project was funded by Torbay Medical Research Fund and supported by the 371 
NIHR Exeter Clinical Research Facility. The views and opinions shown within this paper are 372 
those of the authors and do not necessarily represent those of the NIHR, NHS or the DoH. 373 
We would also like to thank the research nurses and technicians involved in the study and 374 
importantly the volunteers.  375 
Contributorship Statement: 376 
 377 
DW, LD, JK, PW, AJ, NB, MG were involved in the conception or design of the work.  AIS, 378 
DW, LD were involved in the acquisition of data.  AIS, DW, AJ, NB, PW, ACS, MG were 379 
involved in the analysis or interpretation of data.  All authors have been involved in drafting 380 
of the work and revision for intellectually important content.  MG acts as guarantor. 381 
References 382 
 383 
[1] F. Jardin, P. Gueret, J. Prost, J. Farcot, Y. Ozier, J. Bourdarias, Two-dimensional 384 
echocardiographic assessment of left ventricular function in chronic obstructive 385 
pulmonary disease, The American review of respiratory disease 129 (1984) 135-142. 386 
[2] B. Marshall, C. Hanson, F. Frasch, C. Marshall, Role of hypoxic pulmonary 387 
vasoconstriction in pulmonary gas exchange and blood flow distribution, Intensive 388 
care medicine 20 (1994) 379-389. 389 
16 
 
[3] F. Maltais, M. Decramer, R. Casaburi, E. Barreiro, Y. Burelle, R. Debigare, P.N. 390 
Dekhuijzen, F. Franssen, G. Gayan-Ramirez, J. Gea, H.R. Gosker, R. Gosselink, M. 391 
Hayot, S.N. Hussain, W. Janssens, M.I. Polkey, J. Roca, D. Saey, A.M. Schols, M.A. 392 
Spruit, M. Steiner, T. Taivassalo, T. Troosters, I. Vogiatzis, P.D. Wagner, An official 393 
American Thoracic Society/European Respiratory Society statement: update on limb 394 
muscle dysfunction in chronic obstructive pulmonary disease, Am J Respir Crit Care 395 
Med 189 (2014) 201402-0373ST. 396 
[4] C.B. Cooper, Desensitization to dyspnea in COPD with specificity for exercise training 397 
mode, International journal of chronic obstructive pulmonary disease 4 (2009) 33-43. 398 
[5] L. Nici, C. Donner, E. Wouters, R. Zuwallack, N. Ambrosino, J. Bourbeau, M. Carone, B. 399 
Celli, M. Engelen, B. Fahy, C. Garvey, R. Goldstein, R. Gosselink, S. Lareau, N. 400 
MacIntyre, F. Maltais, M. Morgan, D. O'Donnell, C. Prefault, J. Reardon, C. 401 
Rochester, A. Schols, S. Singh, T. Troosters, American Thoracic Society/European 402 
Respiratory Society statement on pulmonary rehabilitation, Am J Respir Crit Care 403 
Med 173 (2006) 1390-413. 404 
[6] M. Gilchrist, P. Winyard, N. Benjamin, Dietary Nitrate - Good or bad?, Nitric Oxide 22 405 
(2010) 104-109. 406 
[7] K. Joshipura, J, F. Hu, B, J. Manson, E, M. Stampfer, J, E. Rimm, B, E. Speizer F, G. 407 
Colditz, A. Ascherio, B. Rosner, D. Spiegelmann, W. Willet, C, The Effect of Fruit 408 
and Vegetable Intake on Risk of Coronary Heart Disease, Annals of Internal Medicine 409 
134 (2001) 1106-1114. 410 
[8] F. Hirayama, A.H. Lee, C.W. Binns, Y. Zhao, T. Hiramatsu, Y. Tanikawa, K. Nishimura, 411 
H. Taniguchi, Do vegetables and fruits reduce the risk of chronic obstructive 412 
pulmonary disease? A case–control study in Japan, Preventive Medicine 49 (2009) 413 
184-189. 414 
[9] L. Watson, B. Margetts, P. Howarth, M. Dorward, R. Thompson, P. Little, The 415 
association between diet and chronic obstructive pulmonary disease in subjects 416 
selected from general practice, European Respiratory Journal 20 (2002) 313-318. 417 
[10] N. Bryan, S, G. Hord. N, Dietary nitrate and nitrites: The physiological context for 418 
potential health benefits/ DEStech Publications, Food, nutrition and the nitric oxide 419 
pathway, 2010. 420 
[11] S. Bailey, J, P. Winyard, A. Vanhatalo, J. Blackwell, R, F. DiMenna, J, D. Wilkerson, P, 421 
J. Tarr, N. Benjamin, A. Jones, M, Dietary nitrate supplementation reduces the O2 422 
cost of low-intensity exercise and enhances tolerance to high-intensity exercise in 423 
humans, American Physiology Society 107 (2009) 1144-1155. 424 
[12] S. Bailey, J , J. Fulford, A. Vanhatalo, P. Winyard, J. Blackwell, R, F. DiMenna, J, D. 425 
Wilkerson, P, N. Benjamin, A. Jones, M, Dietary nitrate supplementation enhances 426 
muscle contractile efficiency during knee-extensor exercise in humans, Journal of 427 
Applied Physiology 109 (2010) 135-148. 428 
[13] A.A. Kenjale, K.L. Ham, T. Stabler, J.L. Robbins, J.L. Johnson, M. VanBruggen, G. 429 
Privette, E. Yim, W.E. Kraus, J.D. Allen, Dietary nitrate supplementation enhances 430 
exercise performance in peripheral arterial disease, Journal of Applied Physiology 431 
110 (2011) 1582-1591. 432 
[14] K. Cosby, K. Partovi, J. Crawford, H, R. Patel, P, C. Reiter, D, S. Martyr, B. Yang, K, 433 
M. Waclawiw, A, G. Zalos, X. Xu, K. Huang, T, H. Shields, D. Kim-Shapiro, B, A. 434 
Schechter, N, R. Cannon III, O, M. Gladwin, T, Nitrite reduction to nitric oxide by 435 
deoxyhemoglobin vasodiltaes the human circulation Nature Medicine 9 (2003) 1498-436 
1505. 437 
[15] T.L. Merry, G.R. Steinberg, G.S. Lynch, G.K. McConell, Skeletal muscle glucose 438 
uptake during contraction is regulated by nitric oxide and ROS independently of 439 
17 
 
AMPK, American Journal of Physiology-Endocrinology and Metabolism 298 (2010) 440 
E577-E585. 441 
[16] F.J. Larsen, T.A. Schiffer, S. Borniquel, K. Sahlin, B. Ekblom, J.O. Lundberg, E. 442 
Weitzberg, Dietary Inorganic Nitrate Improves Mitochondrial Efficiency in Humans, 443 
Cell Metabolism 13 (2011) 149-159. 444 
[17] W.K. Alderton, C.E. Cooper, R.G. Knowles, Nitric oxide synthases: structure, function 445 
and inhibition, 2001. 446 
[18] T.H.J. Florin, G. Neale, J.H. Cummings, The effect of dietary nitrate on nitrate and 447 
nitrite excretion in man, British Journal of Nutrition 64 (1990) 387-397. 448 
[19] C. Duncan, H. Dougall, P. Johnston, S. Green, R. Brogan, L. Smith, M. Golden, N. 449 
Benjamin, Chemical generation of nitric oxide in the mouth from the entrosalivery 450 
circulation of dietary nitrate, Nature Medicine 1 (1995) 546-551. 451 
[20] N. Benjamin, F. O'Driscoll, H. Dougall, C. Duncan, S. Smith, M. Golden, H. McKenzie, 452 
Stomach NO synthesis, Nature 368 (1994) 502. 453 
[21] A. Modin, H. Bjorne, M. Herulf, K. Alving, E. Weitzberg, J. Lundberg, Nitrite-derived 454 
nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation, Acta Physiologica 455 
Scandinavica 171 (2001) 9-16. 456 
[22] E. Fiaccadori, S. Del Canale, P. Vitali, E. Coffrini, N. Ronda, A. Guariglia, SKeletal 457 
muscle energetics, acid-base equilibrium and lactate metabolism in patients with 458 
severe hypercapnia and hypoxemia, Chest 92 (1987) 883-887. 459 
[23] W.L. Beaver, K. Wasserman, B.J. Whipp, A new method for detecting anaerobic 460 
threshold by gas exchange, J Appl Physiol 60 (1986) 2020-2027. 461 
[24] M. Gilchrist, P.G. Winyard, J. Fulford, C. Anning, A. Shore, N. Benjamin, Dietary 462 
nitrate supplementation improves reaction time in type 2 diabetes: Development and 463 
application of a novel nitrate-depleted beetroot juice placebo, Nitric Oxide (2014). 464 
[25] M. Gilchrist, P.G. Winyard, K. Aizawa, C. Anning, A. Shore, N. Benjamin, Effect of 465 
dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 466 
diabetes, Free Radical Biology and Medicine 60 (2013) 89-97. 467 
[26] M.K. Covey, J.L. Larson, S. Wirtz, Reliability of submaximal exercise tests in patients 468 
with COPD. Chronic obstructive pulmonary disease, Medicine and science in sports 469 
and exercise 31 (1999) 1257-1264. 470 
[27] F.J. Larsen, E. Weitzberg, J.O. Lundberg, B. Ekblom, Dietary nitrate reduces maximal 471 
oxygen consumption while maintaining work performance in maximal exercise, Free 472 
Radical Biology and Medicine 48 (2010) 342-347. 473 
[28] R. Bescos, F.A. Rodriguez, X. Iglesias, M.D. Ferrer, E. Iborra, A. Pons, Acute 474 
administration of inorganic nitrate reduces VO(2peak) in endurance athletes, Med Sci 475 
Sports Exerc 43 (2011) 1979-86. 476 
[29] F. Larsen, E. Weitzberg, J. Lundberg, B. Ekblom, Effects of dietary nitrate on oxygen 477 
cost during exercise, Acta Physiologica 191 (2007) 59-66. 478 
[30] D.J. Muggeridge, C.C. Howe, O. Spendiff, C. Pedlar, P.E. James, C. Easton, A Single 479 
Dose of Beetroot Juice Enhances Cycling Performance in Simulated Altitude, Med 480 
Sci Sports Exerc 10 (2013) 10. 481 
[31] L.J. Wylie, J. Kelly, S.J. Bailey, J.R. Blackwell, P.F. Skiba, P.G. Winyard, A.E. 482 
Jeukendrup, A. Vanhatalo, A.M. Jones, Beetroot juice and exercise: 483 
pharmacodynamic and dose-response relationships, J Appl Physiol 115 (2013) 325-484 
36. 485 
[32] K. Mobbs, H. Van Saene, D. Sunderland, P. Davies, Oropharyngeal gram-negative 486 
bacillary carriage in chronic obstructive pulmonary disease: relation to severity of 487 
disease, Respiratory medicine 93 (1999) 540-545. 488 
18 
 
[33] J. Kelly, J. Fulford, A. Vanhatalo, J.R. Blackwell, O. French, S.J. Bailey, M. Gilchrist, 489 
P.G. Winyard, A.M. Jones, Effects of short-term dietary nitrate supplementation on 490 
blood pressure, O2 uptake kinetics, and muscle and cognitive function in older adults, 491 
Am J Physiol Regul Integr Comp Physiol 304 (2013) 21. 492 
[34] A. Vanhatalo, J. Bailey, B, J. Blackwell, R, F. DiMenna, J, T. Pavey, G, D. Wilkerson, 493 
P, N. Benjamin, P. Winyard, A. Jones, M, Acute and chronic effects of dietary nitrate 494 
supplementation on blood pressure and the physiological repsonses to moderate-495 
intensity and incremental exercise American Journal of Physiology - Regulatory, 496 
Integrative and Comparative Physiology 299 (2010) 1121-1131. 497 
[35] K. Lansley, E, P. Winyard, J. Fulford, A. Vanhatalo, J. Bailey, B, J. Blackwell, R, F. 498 
DiMenna, J, M. Gilchrist, N. Benjamin, A. Jones, M, Dietary nitrate supplementation 499 
reduces the O2 cost of walking and running: a placebo-controlled study, Journal of 500 
Applied Physiology 110 (2010) 591-600. 501 
[36] A.J. Kowaltowski, A.E. Vercesi, Mitochondrial damage induced by conditions of 502 
oxidative stress, Free Radical Biology and Medicine 26 (1999) 463-471. 503 
[37] J. Ciencewicki, S. Trivedi, S.R. Kleeberger, Oxidants and the pathogenesis of lung 504 
diseases, The Journal of allergy and clinical immunology 122 (2008) 456-68; quiz 505 
469-70. 506 
[38] H. Li, U. Forstermann, Uncoupling of endothelial NO synthase in atherosclerosis and 507 
vascular disease, Curr Opin Pharmacol 13 (2013) 161-7. 508 
[39] C.P. Bondonno, A.H. Liu, K.D. Croft, N.C. Ward, X. Yang, M.J. Considine, I.B. 509 
Puddey, R.J. Woodman, J.M. Hodgson, Short-term effects of nitrate-rich green leafy 510 
vegetables on blood pressure and arterial stiffness in individuals with high-normal 511 
blood pressure, Free Radic Biol Med (2014). 512 
[40] F. Cacciatore, G. Bruzzese, D.F. Vitale, A. Liguori, F. de Nigris, C. Fiorito, T. Infante, 513 
F. Donatelli, P.B. Minucci, L.J. Ignarro, Effects of ACE inhibition on circulating 514 
endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive 515 
patients, European journal of clinical pharmacology 67 (2011) 877-883. 516 
[41] C. Ceconi, K.M. Fox, W.J. Remme, M.L. Simoons, M. Bertrand, G. Parrinello, C. Kluft, 517 
A. Blann, D. Cokkinos, R. Ferrari, ACE inhibition with perindopril and endothelial 518 
function. Results of a substudy of the EUROPA study: PERTINENT, Cardiovascular 519 
Research 73 (2007) 237-246. 520 
[42] D.S. Jacoby, D.J. Rader, Renin-angiotensin system and atherothrombotic disease: from 521 
genes to treatment, Archives of internal medicine 163 (2003) 1155-1164. 522 
[43] W. Yong-Xiang, K.S. Poon, D.J. Randall, C.C.Y. Pang, Endothelium-derived nitric 523 
oxide partially mediates salbutamol-induced vasodilatations, European Journal of 524 
Pharmacology 250 (1993) 335-340. 525 
[44] M.J. Berry, N.W. Justus, J.I. Hauser, A.H. Case, C.C. Helms, S. Basu, Z. Rogers, M.T. 526 
Lewis, G.D. Miller, Dietary nitrate supplementation improves exercise performance 527 
and decreases blood pressure in COPD patients, Nitric Oxide (2014). 528 
[45] C.P. Bondonno, X. Yang, K.D. Croft, M.J. Considine, N.C. Ward, L. Rich, I.B. Puddey, 529 
E. Swinny, A. Mubarak, J.M. Hodgson, Flavonoid-rich apples and nitrate-rich spinach 530 
augment nitric oxide status and improve endothelial function in healthy men and 531 
women: a randomized controlled trial, Free Radical Biology and Medicine 52 (2012) 532 
95-102. 533 
 534 
 535 
 536 
 537 
19 
 
Figure legends  538 
 539 
• Fig. 1. Parameters of oxygen uptake kinetics. See text for further details. 540 
• Fig. 2.  Plasma nitrate concentration following placebo and beetroot juice 541 
supplementation. The open bar represents placebo and the closed box, beetroot juice. 542 
*significantly different from placebo P < 0.01. 543 
• Fig. 3. The pulmonary oxygen uptake response during the transition from unloaded 544 
cycling to cycling at 80% of the GET for 6 minutes following placebo (A) and 545 
beetroot juice supplementation (B). The vertical line denotes the transition from 546 
baseline to moderate intensity cycling. 547 
• Fig. 4. Systolic (SBP) and diastolic (DBP) blood pressure following placebo and 548 
beetroot juice supplementation. The open bar represents placebo and the closed box, 549 
beetroot juice.  550 
• Table 1. Characteristics of the patients included in the final analyses. Data are mean ± 551 
SD or as a % of the cohort on a medication.   552 
• Table 2. Pulmonary gas exchange during moderate intensity cycling following 553 
placebo and beetroot juice supplementation.  554 
